1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Genetic Testing Market Outlook 2018

Genetic Testing Market Outlook 2018

  • October 2014
  • -
  • RNCOS
  • -
  • 120 pages

A recent report, “Genetic Testing Market Outlook 2018”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in this report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 9% during 2013-2018.

Our report is an outcome of extensive interaction with industry experts which has led us to portray the updated status of genetic testing in various therapeutic areas, major geographies and significant industry applications. The genetic testing industry has seen several new product launches, active research innovations, strategic activities, launch of new DTC tests, and wider therapeutic applications.

The report effectively illustrates the role of genetic testing in diseases such as Cancer, Cystic Fibrosis, and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely, Next-Generation Sequencing, Whole Genome Sequencing, Non Invasive Prenatal Diagnostics, and Personalized Medicine have been covered in the report.

Genetic testing is growing in both developing and developed nations with both industry and research personnel highlighting the significance of molecular biology. The report provides comprehensive analytics of key developments for major markets including the U.S., Europe and Asian countries, and their market overview. Country level analysis depicts the level of penetration for genetic testing, types of tests available, consumer perspectives, regulatory stringency and future growth.

The report also profiles the ten most active genetic testing market players worldwide: Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Life Technologies, Agilent, Hologic, Illumina, Qiagen, Cepheid, and Affymetrix.

Table Of Contents

Genetic Testing Market Outlook 2018
1. Analyst View
2. Research Methodology
3. Genetic Testing Overview
3.1 Application and Advantages
3.2 Methods
4. Global Genetic Testing Market Overview
4.1 Market Outlook
4.2 Genetic Testing Laboratories - Unmet Need Analysis
4.3 Direct-to-Consumer (DTC) Genetic Testing
5. Disease-Wise Analysis
5.1 Alzheimer's Disease
5.2 Cystic Fibrosis
5.3 Cancer
6. Country-Level Analysis
6.1 US
6.1.1 Market Overview
6.1.2 Recent Developments
6.2 Europe
6.2.1 Market Overview
6.2.2 Recent Developments
6.3 Asia
6.3.1 Market Overview
6.3.2 Recent Developments
7. Emerging Sectors
7.1 Next-Generation Sequencing (NGS)
7.2 Non-Invasive Prenatal Testing (NIPT)
7.3 Whole Genome Sequencing (WGS) for Cancer
7.4 Personalized Medicine
8. Genetic Testing Regulation
9. Competitive Assessment
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Product Offering
9.1.3 Key Financials
9.1.4 Recent Developments
9.1.5 Strengths and Weaknesses
9.2 Roche Diagnostics
9.2.1 Company Overview
9.2.2 Product Offering
9.2.3 Key Financials
9.2.4 Recent Developments
9.2.5 Strengths and Weaknesses
9.3 Myriad Genetics, Inc.
9.3.1 Company Overview
9.3.2 Product Offering
9.3.3 Key Financials
9.3.4 Recent Developments
9.3.5 Strengths and Weaknesses
9.4 Life Technologies Corporation (Thermo Fisher Scientific)
9.4.1 Company Overview
9.4.2 Product Offering
9.4.3 Key Financials
9.4.4 Recent Developments
9.4.5 Strengths and Weaknesses
9.5 Agilent Technologies Inc.
9.5.1 Company Overview
9.5.2 Product Offering
9.5.3 Key Financials
9.5.4 Recent Development
9.5.5 Strengths and Weaknesses
9.6 Hologic, Inc.
9.6.1 Company Overview
9.6.2 Product Offering
9.6.3 Key Financials
9.6.4 Recent Developments
9.6.5 Strengths and Weaknesses
9.7 Illumina, Inc.
9.7.1 Company Overview
9.7.2 Product Offering
9.7.3 Key Financials
9.7.4 Recent Developments
9.7.5 Strengths and Weaknesses
9.8 Qiagen NV
9.8.1 Company Overview
9.8.2 Products Offering
9.8.3 Key Financials
9.8.4 Recent developments
9.8.5 Strengths and Weaknesses
9.9 Cepheid
9.9.1 Company Overview
9.9.2 Product Offering
9.9.3 Key Financials
9.9.4 Recent developments
9.9.5 Strengths and Weakness
9.10 Affymetrix, Inc.
9.10.1 Company Overview
9.10.2 Product Offering
9.10.3 Key Financials
9.10.4 Recent Developments
9.10.5 Strength and Weakness

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2013-2018
Figure 4-2: Genetic Testing Market by Geography (%), 2013
Figure 4-3: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-4: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Disorder, Genes, Labs, and Clinics for Genetic Testing (2013 and 2014)
Figure 6-2: Number of Genetic Tests (2013 and 2014)
Figure 6-3: US - Number of Genetic Tests Available in the Market (2008 and 2012)
Figure 6-4: US - Genetic Testing Equipment Market (Billion US$), 2013-2018
Figure 6-5: Europe - Genetic Testing Equipment Market (Billion US$), 2013-2018
Figure 7-1: Global - Next Generation Sequencing Market (Billion US$), 2013-2018
Figure 7-2: Global - NGS Application by Sector (%)
Figure 7-3: Global - Next Generation Sequencing Market by Player (%), 2012
Figure 7-4: US - Non-Invasive Prenatal Testing Market (Million US$), 2013-2018
Figure 7-5: US - Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 7-6: US - Personalized Cancer WGS Market (Million US$), 2013-2018
Figure 7-7: Organizational Transformation to Support Personalized Medicine
Figure 8-1: Genetic Testing Regulatory Agencies
Figure 9-1: Abbott Laboratories - Revenue Breakup by Geography (%), 2013
Figure 9-2: Abbott Laboratories - Revenue Breakup by Diagnostics Division (%), 2013
Figure 9-3: Roche Holding - Diagnostic Division Revenue by Geography (%), 2013
Figure 9-4: Roche Holding - Revenue Breakup by Business Division (%), 2013
Figure 9-5: Myriad Genetics - Revenue Breakup by Business Segment (%), 2013
Figure 9-6: Life Technologies - Revenue Breakup by Geography (%), 2012
Figure 9-7: Life Technologies - Revenue Breakup by Business Segment (%), 2012
Figure 9-8: Agilent - Revenue Breakup by Business Segment (%), 2013
Figure 9-9: Hologic - Revenue Breakup by Business Segment (%), 2013
Figure 9-10: Hologic - Revenue Breakup by Geography (%), 2013
Figure 9-11: Illumina - Revenue Breakup by Geography (%), 2013
Figure 9-12: Qiagen NV - Revenue Break up by Business Segment (%), 2013
Figure 9-13: Qiagen NV - Revenue Break up by Geography (%), 2013
Figure 9-14: Cepheid - Revenue Break up by Business Segment (%), 2013
Figure 9-15: Cepheid - Revenue Break up by Geography (%), 2013
Figure 9-16: Affymetrix - Revenue Breakup by Geography (%), 2013
Figure 9-17: Affymetrix - Revenue Breakup by Business Segment (%), 2013

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment
Table 7-1: FDA Approved Pharmacogenomic Biomarkers for Oncology
Table 9-1: Abbott Laboratories - Key Gene Based Products
Table 9-2: Abbott Laboratories - Financial Performance (Million US$), 2010-2012
Table 9-3: Roche Molecular Diagnostics - Key Gene Based Products
Table 9-4: Roche Holding - Financial Performance (Million CHF), 2011-2013
Table 9-5: Myriad Genetics - Key Gene Based Products
Table 9-6: Myriad Genetics - Financial Performance (Million US$), 2011-2013
Table 9-7: Life Technologies - Key Gene Based Products
Table 9-8: Life Technologies - Financial Performance (Million US$), 2010-2012
Table 9-9: Agilent - Key Gene Based Products
Table 9-10: Agilent - Financial Performance (Million US$), 2011-2013
Table 9-11: Hologic - Key Gene Based Products
Table 9-12: Hologic - Financial Performance (Million US$), 2011-2013
Table 9-13: Illumina - Key Gene Based Products
Table 9-14: Illumina - Financial Performance (Million US$), 2011-2013
Table 9-15: Qiagen NV - Key Gene Based Products
Table 9-16: Qiagen NV - Financial Performance (Million US$), 2011-2013
Table 9-17: Cepherid - Key Gene Based Products
Table 9-18: Cepheid - Financial Performance (Million US$), 2011-2013
Table 9-19: Affymetrix - Key Gene Based Products
Table 9-20: Affymetrix - Financial Performance (Million US$), 2011-2013

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

The Market for Prenatal, Newborn and Carrier Genetic Testing

The Market for Prenatal, Newborn and Carrier Genetic Testing

  • $ 4 200
  • Industry report
  • May 2015
  • by Kalorama Information

The Market for Prenatal, Newborn and Carrier Genetic Testing provides the world markets for prenatal, newborn, postnatal, and carrier genetic testing for 2014 to 2019. In addition, company revenues are ...

Global Genetic Testing Market 2015-2019

Global Genetic Testing Market 2015-2019

  • $ 2 500
  • Industry report
  • July 2015
  • by Infiniti Research Limited

About Genetic Testing Genetic testing is the most profitable and rapidly expanding segment of molecular diagnostics. It is the array of techniques used for the analysis of DNA, RNA, and protein. It is ...

Global Cancer Diagnostics(Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry Report 2015

Global Cancer Diagnostics(Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry Report 2015

  • $ 2 800
  • Industry report
  • July 2015
  • by QY Research Group

Summary The Global Cancer Diagnostics(Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry Report 2015 is a professional and in-depth study on the current state of the Cancer Diagnostics(Tumo ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in Africa

  • July 2015
    30 pages
  • Genetic  

  • Africa  

    United States  

View report >

The future of the Genetic Industry in Madagascar

  • July 2015
    8 pages
  • Genetic  

  • Madagascar  

View report >

Genomics Industry in the UK

  • July 2015
    10 pages
  • Genomics  

    Nucleotide  

  • United Kingdom  

View report >

Genomics Market Size

1 month ago

Related Market Segments :

Genetic

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.